Pill imprint M L53 has been identified as Lamotrigine 150 mg.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy.
Lamotrigine 150 mg is not subject to the Controlled Substances Act.
Click on the link to view an image of the pill:
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 13 Jul 2011 • 1 answer
Posted 26 Apr 2017 • 0 answers
Posted 26 May 2017 • 1 answer
Posted 27 May 2017 • 1 answer
Posted 16 Jun 2017 • 0 answers